Answers are grounded in this paper and cite their sources.
This systematic review updates treatment recommendations for WHO Grade II diffuse glioma, indicating crucial management strategies.
This series of guideline documents provides an update of the information and recommendations provided in the 2015 version. It sets a benchmark as to the published information we have to support the management of this difficult disease. It also provides clues to key investigations that are necessary to move us toward effective control of WHO grade II diffuse gliomas.
No takes yet. Share an insight, caveat, or question.
Ormond et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: